In partnership with

Today’s market looks irrational on the surface: strong earnings ignored, quality companies sold indiscriminately, and defensive stocks trading at innovation-era multiples. But beneath the volatility lies a deeper struggle—investors trying to price an uncertain future all at once. AI acceleration, policy ambiguity, and valuation discomfort have collided, creating violent rotations rather than broad exits. As a result, scenarios are mistaken for outcomes and patience is penalized. This isn’t dysfunction—it’s a market grappling with transition.

At the end, we connect this emotional rotation to real company results and explain why moments like this quietly seed long-term returns. Read the full newsletter to understand why refusing to confuse panic with truth may be the most valuable investment decision right now.

Let’s embark on this transformative journey together and position your portfolio for success in this evolving market landscape!

Be sure to read through to the end to catch all the valuable insights this newsletter delivers to your inbox today.

Nuclear Stocks Are Up 40%+ - Here’s What’s Driving It

Some market trends take years to really pan out.

Nuclear energy isn’t one of them.

Over the past year, multiple nuclear-related stocks climbed more than 40% as the next nuclear buildout cycle began taking shape heading into 2026...

Driven by real earnings, real contracts, and real demand.

One uranium producer generated nearly $200 million in quarterly free cash flow as prices surged.

Another nuclear-focused company locked in long-term government contracts that helped push revenue higher…

Without relying on commodity swings.

Our analysts pulled together a shortlist of these companies and a select few more - All of them benefiting from nuclear’s return to relevance as U.S. capacity is projected to triple over the coming decades.

The names and tickers are in this new report.

7 Top Nuclear Stocks to Buy Now

Riding BSX's Wave: Medical Device Strength and Steady $500 Monthly Builds

Picture this: Five years ago, Boston Scientific $BSX ( ā–¼ 0.82% ) stock was trading for just about $39.54 a share. Fast forward to today, it's sitting at $76.85—that's a strong 94% jump. The chart tells the tale of a steady climb, with some dips along the way, but overall, it's been a solid ride from lower levels in 2022 to this current spot now. Even with a 52-week high of $109.50 still in sight, the momentum feels real.

To make sense of that growth, let's talk numbers without the jargon. The compound annual growth rate (CAGR) over those five years clocks in at about 14.2%. In plain terms, if the stock keeps pacing itself like history suggests, it's like earning over 14% each year on average.

Now, imagine you're jumping in with dollar-cost averaging (DCA)—that smart strategy of investing a fixed amount regularly, no matter the price swings. You drop $500 every month for the next five years, totaling $30,000 out of pocket. By spreading it out over 60 months, you buy more shares when prices dip and fewer when they peak, smoothing out the ride.

Turn AI into Your Income Engine

Ready to transform artificial intelligence from a buzzword into your personal revenue generator?

HubSpot’s groundbreaking guide "200+ AI-Powered Income Ideas" is your gateway to financial innovation in the digital age.

Inside you'll discover:

  • A curated collection of 200+ profitable opportunities spanning content creation, e-commerce, gaming, and emerging digital markets—each vetted for real-world potential

  • Step-by-step implementation guides designed for beginners, making AI accessible regardless of your technical background

  • Cutting-edge strategies aligned with current market trends, ensuring your ventures stay ahead of the curve

Download your guide today and unlock a future where artificial intelligence powers your success. Your next income stream is waiting.

If BSX mirrors its past five-year performance, here's how it plays out: Each monthly chunk grows at a blended monthly rate of about 1.1% (derived from the annual CAGR). After 60 months, your total pot? A healthy $42,362. That's a gain of $12,362 on your $30,000 investment—a 41% return overall. Not bad for consistent, no-fuss investing.

Of course, past growth doesn't guarantee the future—markets can shift, and BSX's focus on medical devices means it ties into healthcare innovation and patient care trends. But if you're eyeing that 52-week high of $109.50 as a sign of more upside, this DCA approach could turn your steady $500 habit into a real nest egg by 2031. Ready to let history inspire your next move?

āš ļøšŸ“ŠWhen Markets Don’t React to Facts, They React to Feelings

Markets didn’t unravel because earnings collapsed. They didn’t break because balance sheets deteriorated. They didn’t even fall apart because growth disappeared.

They stumbled because a story resurfaced at the exact moment investors were already uneasy.

A widely circulated Substack essay laid out a hypothetical AI-driven future, framed explicitly as a scenario, not a prediction. Yet the market treated it as inevitability. That response says far more about current sentiment than about the essay itself.

This pattern should feel familiar. Extreme downside narratives rarely gain traction during rallies. They surface after prices have already weakened, when confidence is fragile and positioning is crowded. At that point, fear spreads faster than nuance.

The result?
A market that appears irrational on the surface:

  • Exceptional earnings are ignored

  • Strong guidance fails to matter

  • High-quality companies sell off indiscriminately

This is not a broken market. It is a conflicted one—struggling to reconcile technological acceleration, policy uncertainty, and valuation discomfort all at once.

The AI ā€œDoom Loopā€: A Scenario Mistaken for Destiny

The core thesis of the essay was straightforward:
AI displaces enough white-collar labor to weaken consumer spending (which represents roughly 70% of U.S. GDP), triggering a self-reinforcing cycle of layoffs, automation, and demand destruction.

That scenario is not new.

Concerns around job displacement, government unpreparedness, and economic adjustment have existed since the earliest days of AI commercialization. What changed was timing—not substance.

The essay itself emphasized this was a thought exercise, not a forecast. Yet markets reacted as if the outcome were locked in.

This is where perspective matters.

Every major technological shift has sparked similar fears—from mechanization to computers to the internet. Each time, jobs changed rather than vanished outright. AI may be different—but so far, history still argues against instant collapse.

More importantly, the essay assumes institutions will fail to adapt. That skepticism may be justified—but it is not evidence.

Policy responses, corporate restructuring, and labor reallocation do not happen overnight. They evolve. Markets, however, attempt to price the endgame immediately.

That mismatch is what creates volatility—not inevitability.

Rotation Without Logic: Valuations Tell a Strange Story

One of the most overlooked developments right now is where money is actually flowing.

This is not a broad exit from equities. It’s a violent rotation.

Slower-growing, lower-margin businesses are being rewarded with valuation multiples approaching—or exceeding—those of high-growth, high-margin technology leaders. Retail, staples, and perceived ā€œsafetyā€ are trading at levels once reserved for innovation.

Meanwhile, profitable technology companies with durable growth are being discounted aggressively.

This inversion reveals confusion, not conviction.

Markets are attempting to hide from uncertainty, even if that means overpaying for stability. Whether that stability holds at 45–50x earnings remains an open question.

Historically, these environments don’t persist. They unwind—sometimes quietly, sometimes abruptly.

For patient investors, this distortion matters more than daily price action.

Ray Dalio: "The S&P Fell 28% Last Year." Wait, What?

He's measuring in gold, not dollars. And that's the point.

The dollar dropped 10% in 2025. So, yeah, your portfolio went up in dollars, but, Dalio says your real return isn’t so exciting.

And the decline is reportedly advancing as macro conditions don’t improve.

So, what investments offer protection against that currency risk?

Well.. billionaires have an answer. And now 70,819 everyday investors have joined in.

This unexpected asset class outpaced the S&P 500 overall with low correlation since 1995.*

Not real estate or PE. Post war and contemporary art. Seriously.

Plus– Art trades globally ;)

And now, you don’t need to be a billionaire–

Masterworks makes it easy to FRACTIONALLY invest in blue-chip art, with a track record of 26 net annualized returns like 14.6%, 17.6%, and 17.8% on works held over a year.

See why investors moved $1.3 billion into 500+ offerings:

*According to Masterworks data.Ā  Investing involves risk. Past performance not indicative of future returns. See important disclosures at masterworks.com/cd.

Earnings Reality: Growth Is Alive, Investment Is the Villain

Operationally, MercadoLibre continues to deliver one of the strongest growth profiles in public markets:

  • Gross merchandise volume up 37%

  • Items sold up 43%

  • Total payment volume up 42%

  • Credit portfolio growth of 90%

  • Revenue and financial income up 45%

  • Operating income of $891M

  • Net income of $559M

  • Adjusted free cash flow of $763M

The market reaction focused on margin compression:

  • Operating margins down 340 basis points

  • Net margins down 410 basis points

This was not unexpected—and management made no attempt to soften the message. Investment is being prioritized over optics. This is not the first investment cycle, and history suggests it won’t be the last.

Nearly 28 consecutive quarters of 30%+ growth is not noise. It is execution.

Nu Holdings $NU ( ā–² 1.4% )

Nu continues to execute profitably while scaling aggressively:

  • Strong growth across deposits, lending, and users

  • Expanding financial ecosystem

  • Clear profitability trajectory

The market reaction centered on geographic expansion, not performance. Management has been explicit: Latin America remains the core engine, while selective global expansion represents optionality—not distraction.

The sell-off reflects discomfort, not deterioration.

Salesforce delivered:

  • 12% quarterly revenue growth

  • $41.5B in annual revenue (+10%)

  • Remaining performance obligations up 14% to $72B

  • AI-driven ARR exceeding $2.9B, up 200% YoY

  • Raised long-term revenue target to $63B by FY2030

  • Still targeting Rule of 50

The valuation remains compelling—but the market wants acceleration. Until growth re-inflects, the multiple may remain compressed.

This is not a broken business. It is a waiting game.

Shift4: Where Patience Is the Strategy

Shift4’s quarter was fundamentally strong:

  • Gross profit up 58%

  • Revenue less network fees up 51%

  • Adjusted EBITDA margin near 50%

  • Leadership positions across restaurants, hospitality, sports, and luxury retail

  • Operations spanning 75+ countries

The pressure point is timing.

The Global Blue acquisition introduced:

  • Temporary margin drag

  • Higher interest expense

  • Integration costs

Management has been clear: synergies are a second-half-2026 story.

Guidance reflected caution:

  • Volume growth 15–24%

  • Revenue growth 26–31%

  • Adjusted EBITDA growth 20–25%

  • EPS guidance below expectations

  • Free cash flow conversion temporarily muted

This is not denial—it is transparency.

Notably:

  • $1B share repurchase program (half already executed)

  • ~17% of shares retired since IPO

  • Founder relinquished super-voting control

  • Corporate governance strengthened

Return on invested capital has dipped, as expected post-acquisition. That metric will be the scoreboard.

This is not a moment that demands urgency. It demands verification.

Closing Perspective — When Markets Feel Uninvestable

This market feels hostile because it is pricing uncertainty, not outcomes.

Fear is louder than data. Scenarios are being treated as certainties. Long-term investments are being judged quarter-to-quarter.

That tension doesn’t last forever.

Historically, periods like this—where nothing seems investable and logic appears suspended—are precisely when long-term returns are quietly seeded.

Not through prediction. Through patience. Through discipline. Through refusing to confuse panic with truth.

Ready to Revolutionize Your Wealth?

Here's what's waiting for you:

  • šŸ“ˆ Step-by-Step Guide: Start Investing in Minutes with Our Chosen Online Broker

  • šŸ” Expert Insights: Uncover the Strategies Behind Our Recommended Smart Portfolios

  • šŸ’¼ Easy Diversification: Gain Exposure to a Wide Range of Assets with Just a Few Clicks

  • šŸ’° Long-Term Growth Potential: Build a Portfolio for Consistent Returns Over Time.

Fast Track to Build a Winning Portfolio Blueprint

Fast Track to Build a Winning Portfolio Blueprint

Transform your investment journey with our step-by-step guide, enabling you to start investing in minutes through our trusted online broker. Discover expert insights into our smart portfolios that ...

$70.00 usd

šŸ’ø Paying the bills

A Simpler Way to Explore GLP-1 Weight Loss Support

A Simpler Way to Explore GLP-1 Weight Loss Support

Brightmeds connects you with personalized, clinician-guided access to compounded GLP-1 therapies that can help support weight loss, appetite control, and metabolic balance all from home.

No clinic visits. No waiting rooms. Transparent pricing.

Get Started

Compounded medications are only indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product. Compounded medications are not reviewed by the FDA for safety, efficacy, or quality.

Refind - Brain food is delivered daily. Every day, we analyze thousands of articles and send you only the best, tailored to your interests. Loved by 510,562 curious minds. Subscribe.

TOP MARKET NEWS

Top Market News - March 3, 2026

Top Market News - March 3, 2026

Dear Reader, today’s highlights focus on the case for international investing, global market movements, capital flowing into overseas stocks, and energy sector opportunities.

Why International Investing Still Pays Off

Kellogg Insight explains how international diversification can enhance returns and reduce risk, even in a U.S.-dominated market cycle.

Tip: Global exposure can help balance portfolios when U.S. markets become overconcentrated.

Saudi Arabia Stocks Slip as Tadawul Closes Lower

Investing.com reports on declines in Saudi Arabia’s stock market, highlighting sector performance and regional market sentiment.

Tip: Monitoring global markets can reveal risks and opportunities beyond domestic headlines.

$104 Billion Is Flowing Into International Stocks

Yahoo Finance examines a surge of capital moving into international equities as investors seek diversification and valuation opportunities.

Tip: Strong fund flows can signal growing confidence in overseas markets.

2 No-Brainer Energy Stocks to Buy Right Now

The Motley Fool highlights two energy companies benefiting from strong cash flows, disciplined spending, and favorable market conditions.

Tip: Energy stocks can provide income and inflation protection during volatile market periods.

PROMO CONTENT

Can email newsletters make money?

As the world becomes increasingly digital, this question will be on the minds of millions seeking new income streams in 2026.

The answer is—Absolutely!

That’s it for this episode!

Thank you for taking the time to read today’s email! Your support is what allows me to send out this newsletter for free every day.Ā 

Ā What do you think of the new format?Ā Please provide your feedback in the poll below, and if you find the newsletter valuable, feel free to share it with other investors!

How would you rate today's newsletter?

If you vote 1 or 3 stars, please comment with what you didn't like so we can improve it.

Login or Subscribe to participate

Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Please consult with a financial advisor before making any investment decisions.

Reply

Avatar

or to participate

Keep Reading